Nymox Pharmaceutical
NYMX
#10188
Rank
A$27.44 M
Marketcap
Country
A$0.30
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): A-$0.09066

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is A-$0.09022. In 2022 the company made an earnings per share (EPS) of A-$0.12 an increase over its 2021 EPS that were of A-$0.23.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$0.09066-24.64%
2022A-$0.12-46.67%
2021A-$0.23-11.76%
2020A-$0.26-15%
2019A-$0.305.26%
2018A-$0.29-26.92%
2017A-$0.39-7.14%
2016A-$0.42-40.43%
2015A-$0.71291.67%
2014A-$0.18-7.69%
2013A-$0.20-43.48%
2012A-$0.35-25.81%
2011A-$0.4755%
2010A-$0.3025%
2009A-$0.240.08%
2008A-$0.24-11.12%
2007A-$0.27-0.16%
2006A-$0.2728.59%
2005A-$0.21-12.49%
2004A-$0.24-16.05%
2003A-$0.2919.07%
2002A-$0.2414.45%
2001A-$0.21-22.16%
2000A-$0.275.64%
1999A-$0.26-34.59%
1998A-$0.39-3.6%
1997A-$0.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
A$12.12-13,528.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.59-2,966.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$12.99-14,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$30.85-34,297.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$15.70-17,499.00%๐Ÿ‡บ๐Ÿ‡ธ USA